- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.25 | 1.95 |
NAV | ₹281.56 | ₹414.34 |
Fund Started | 01 Aug 2005 | 04 Jun 1999 |
Fund Size | ₹1187.02 Cr | ₹3416.13 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.25
1.95
NAV
₹281.56
₹414.34
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1187.02 Cr
₹3416.13 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 43.02% | 43.09% |
3 Year | 19.71% | 23.08% |
5 Year | 27.12% | 28.44% |
1 Year
43.02%
43.09%
3 Year
19.71%
23.08%
5 Year
27.12%
28.44%
Holding Analysis
Equity | 98.47% | 96.73% |
Cash | 1.41% | 3.27% |
Equity
98.47%
96.73%
Cash
1.41%
3.27%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.29% |
Cipla Ltd. | 5.89% |
Ajanta Pharma Ltd. | 5.38% |
Dr. Reddy's Laboratories Ltd. | 4.67% |
Gland Pharma Ltd. | 3.70% |
Glenmark Pharmaceuticals Ltd. | 3.57% |
Apollo Hospitals Enterprise Ltd. | 3.55% |
Fortis Healthcare Ltd. | 3.34% |
Procter & Gamble Health Ltd. | 3.26% |
Eris Lifesciences Ltd. | 3.07% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.99% |
Max Healthcare Institute Ltd. | 6.26% |
Divi's Laboratories Ltd. | 6.21% |
Poly Medicure Ltd. | 5.38% |
Lupin Ltd. | 5.12% |
Lonza Group Ag | 4.55% |
Cipla Ltd. | 4.54% |
Krishna Institute of Medical Sciences Ltd | 3.99% |
Jupiter Life Line Hospitals Ltd. | 3.54% |
Mankind Pharma Ltd. | 3.51% |
Fund Manager
Name | Kamal Gada | Tanmaya Desai |
Start Date | 02 May 2022 | 27 Jun 2011 |
Name
Kamal Gada
Tanmaya Desai
Start Date
02 May 2022
27 Jun 2011
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 01 Aug 2005 | 04 Jun 1999 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999
